glp 1 drugs and vision loss Popular GLP-1 medications used to treat type 2 diabetes obesity—semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound)—may be linked to a small increase in the risk of a rare eye Study finds rare vision issues
Description
Ahmed Mohamed Hamdy: Conceptualization
With a cutoff of a BMI of 40, 3% (3.6 million) of adults with employer-sponsored insurance would still qualify
Insurance often wont pay for the pricey meds, but theyre transforming the weight and health of millions, even working for many people whove struggled to slim down for years or decades
Front Immunol
So blood glucose was less, where if you took it intravenously, it would spike and stay up
Once-weekly dulaglutide for the treatment of youths with type 2 diabetes
